Track topics on Twitter Track topics that are important to you
Based in Morrisville, North Carolina, Trimeris was founded in 1993 by leading researchers in the study of the human immunodeficiency virus (HIV). Their work in the early 1990s led to a breakthrough in the fight against AIDS — an entirely new class of anti-HIV drugs called fusion inhibitors. In this section, you will find more information about our history, as well as the Trimeris mission, our leadership teams, strategic alliances, and how we give back to the communities that we serve.
3500 Paramount Parkway
United States of America
Phone: (919) 419-6050
Fax: (919) 419-1816
NEW YORK and SAN DIEGO, Feb. 23, 2012 /PRNewswire/ -- Caxton Advantage Venture Partners, L.P. ("Caxton Advantage"), the life sciences venture capital firm founded in 2006 by Dr. Rach...
Trimeris, Inc. (Nasdaq: TRMS) is a biopharmaceutical company engaged in the commercialization of therapeutic agents for the treatment of viral disease. The core technology platfor...
Based in Morrisville, North Carolina, Trimeris was founded in 1993 by leading researchers in the study of the human immunodeficiency virus (HIV). Their work in the early 1990s led to a breakthrough in...
We have published hundreds of Trimeris news stories on BioPortfolio along with dozens of Trimeris Clinical Trials and PubMed Articles about Trimeris for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Trimeris Companies in our database. You can also find out about relevant Trimeris Drugs and Medications on this site too.
AIDS and HIV
AIDS; Acquired Immune Deficiency Syndrome. HIV; Human Immunodeficiency Virus HIV infection causes AIDS. HIV infection also causes the production of anti-HIV antibodies, which forms the test for HIV in patients. People who have the HIV antibodies are ...